When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharma -42% after FDA OKs Firdapse competitor
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (NASDAQ:CPRX) -42.7% after-hours following the Food and Drug Administration's approval of a competitor to its Firdapse drug that helps patients who suffer from Lambert-Eaton myasthenic syndrome, for which CPRX charges a list price of $375K.
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,